Skip to main content

NASDAQ:TLGT - Teligent Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $2.00
  • Forecasted Upside: 295.49 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.51
▲ +0.01 (2.02%)
1 month | 3 months | 12 months
Get New Teligent Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TLGT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TLGT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$2.00
▲ +295.49% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Teligent in the last 3 months. The average price target is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 295.49% upside from the last price of $0.51.

Hold

The current consensus among 1 contributing investment analysts is to hold stock in Teligent. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/20/2020Craig HallumDowngradeBuy ➝ Hold$2.00High
i
10/3/2019Raymond JamesDowngradeOutperform ➝ Market PerformHigh
i
3/19/2019Raymond JamesDowngradeStrong-Buy ➝ OutperformHigh
i
11/16/2018Canaccord GenuityLower Price TargetHold ➝ Hold$40.00 ➝ $30.00High
i
Rating by Dewey Steadman at Canaccord Genuity
8/13/2018Canaccord GenuitySet Price TargetHold$40.00High
i
Rating by Dewey Steadman at Canaccord Genuity
7/31/2018Canaccord GenuitySet Price TargetHold$40.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
7/25/2018Canaccord GenuitySet Price TargetHold$40.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
7/2/2018Canaccord GenuityReiterated RatingHold$40.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
5/9/2018Canaccord GenuitySet Price TargetHold$40.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
3/15/2018Canaccord GenuitySet Price TargetHold$40.00High
i
Rating by Dewey Steadman at Canaccord Genuity
3/2/2018Canaccord GenuityLower Price TargetHold ➝ Hold$40.00 ➝ $35.00Medium
i
Rating by Dewey Steadman at Canaccord Genuity
12/9/2017Canaccord GenuitySet Price TargetHold$40.00High
i
Rating by Dewey Steadman at Canaccord Genuity
11/7/2017Canaccord GenuityDowngradeBuy ➝ Hold$90.00 ➝ $50.00N/A
i
Rating by Dewey Steadman at Canaccord Genuity
8/23/2017Roth CapitalSet Price TargetBuy$90.00Low
i
Rating by Scott Henry at Roth Capital
8/14/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$90.00 ➝ $80.00Low
i
8/9/2017Roth CapitalSet Price TargetBuy$90.00Medium
i
Rating by Scott Henry at Roth Capital
8/8/2017Canaccord GenuityReiterated RatingBuy$110.00High
i
Rating by Dewey Steadman at Canaccord Genuity
7/31/2017Canaccord GenuityInitiated CoverageBuy ➝ Buy$110.00High
i
7/17/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$80.00 ➝ $90.00High
i
10/28/2016Roth CapitalSet Price TargetBuy$100.00N/A
i
Rating by Scott Henry at Roth Capital
6/29/2016JMP SecuritiesInitiated CoverageHoldN/A
i
6/22/2016Raymond JamesInitiated CoverageStrong-Buy$110.00N/A
i
(Data available from 5/16/2016 forward)
Teligent logo
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Read More

Today's Range

Now: $0.51
$0.48
$0.52

50 Day Range

MA: $0.59
$0.50
$0.70

52 Week Range

Now: $0.51
$0.46
$5.94

Volume

1,370,446 shs

Average Volume

5,264,869 shs

Market Capitalization

$11.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79

Frequently Asked Questions

What sell-side analysts currently cover shares of Teligent?

The following Wall Street analysts have issued stock ratings on Teligent in the last twelve months: Craig Hallum.
View the latest analyst ratings for TLGT.

What is the current price target for Teligent?

1 Wall Street analysts have set twelve-month price targets for Teligent in the last year. Their average twelve-month price target is $2.00, suggesting a possible upside of 295.5%. Craig Hallum has the highest price target set, predicting TLGT will reach $2.00 in the next twelve months. Craig Hallum has the lowest price target set, forecasting a price of $2.00 for Teligent in the next year.
View the latest price targets for TLGT.

What is the current consensus analyst rating for Teligent?

Teligent currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TLGT, but not buy more shares or sell existing shares.
View the latest ratings for TLGT.

What other companies compete with Teligent?

How do I contact Teligent's investor relations team?

Teligent's physical mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company's listed phone number is 856-697-1441 and its investor relations email address is [email protected] The official website for Teligent is www.teligent.com.